Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer’s Disease and Related Dementias: A Cluster Analysis

Manuscript Number: 

22-0573R1

Author(s): 
Barbara Helen Bardenheier, Stefan Gravenstein, Eric Jutkowitz, Linda J. Resnik

Disclosures

Barbara Helen Bardenheier

  • Nothing to Disclose

Stefan Gravenstein

  • Consulting Fees:
    Advisory boards and consulting related to vaccine and antivirals for Seqirus, Sanofi, Merck, Pfizer, Novavax, Vaxart, Janssen, Moderna, Genentech, Reviral.
    Lecture Fees:
    Speaker fees related vaccines or infectious diseases from Janssen, Pfizer, Seqirus, Sanofi, Merck.
    Grants
    • Agency: 
      Pfizer
      Dates: 
      end 2022
    • Agency: 
      Seqirus
      Dates: 
      end 2022
    • Agency: 
      Sanofi
      Dates: 
      end 2023
    • Agency: 
      Genentech
      Dates: 
      end 2024
    • Agency: 
      resTORbio
      Dates: 
      end 2021

Eric Jutkowitz

  • Nothing to Disclose

Linda J. Resnik

  • Nothing to Disclose